Legal Representation
Attorney
Ted Whitlock
USPTO Deadlines
Application History
25 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 10, 2008 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Sep 10, 2008 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Sep 4, 2008 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 6, 2008 | UNDC | O | UNDELIVERABLE MAIL - COURTESY COPY MAILED | Loading... |
| Feb 6, 2008 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 6, 2008 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 6, 2008 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
| Feb 5, 2008 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Jan 4, 2008 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Jan 4, 2008 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Dec 1, 2007 | EX2G | S | EXTENSION 2 GRANTED | Loading... |
| Nov 13, 2007 | EXT2 | S | EXTENSION 2 FILED | Loading... |
| Nov 13, 2007 | EEXT | I | TEAS EXTENSION RECEIVED | Loading... |
| May 11, 2007 | EX1G | S | EXTENSION 1 GRANTED | Loading... |
| May 11, 2007 | EXT1 | S | EXTENSION 1 FILED | Loading... |
| May 11, 2007 | EEXT | I | TEAS EXTENSION RECEIVED | Loading... |
| Nov 22, 2006 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Nov 14, 2006 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 22, 2006 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 2, 2006 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Jul 3, 2006 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Jun 27, 2006 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jun 19, 2006 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 19, 2006 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 28, 2005 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | Loading... |
Detailed Classifications
Class 005
separable pharmaceutical tablets for preventing or treating conditions, diseases or disorders of the cardiovascular, central nervous system, dermatologic, endocrine, gastric or gastroenteric, hematologic, immunologic, inflammatory, osteologic, or respiratory systems; pharmaceutical preparations for use in prevention or treatment of allergies or allergic responses, metabolic disorders, psychiatric or emotional disorders, infection or infectious diseases
First Use Anywhere:
Aug 1, 2006
First Use in Commerce:
Aug 1, 2006
Classification
International Classes
005